Intellia Therapeutics Inc. (NTLA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Intellia Therapeutics Inc...

    NASDAQ: NTLA · Real-Time Price · USD
    16.31
    -0.30 (-1.81%)
    At close: Sep 26, 2025, 3:59 PM
    16.29
    -0.12%
    After-hours: Sep 26, 2025, 07:50 PM EDT

    Intellia Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 57.88M 36.27M 52.12M 33.05M
    Cost of Revenue
    		 10.29M 8.98M 7.57M 6.89M
    Gross Profit
    		 47.59M 27.3M 44.55M 26.16M
    Operating Income
    		 -534.26M -515.29M -458.16M -267.85M
    Interest Income
    		 47.81M 49.83M 8.54M 1.28M
    Pretax Income
    		 -519.02M -481.19M -474.19M -267.89M
    Net Income
    		 -519.02M -481.19M -474.19M -267.89M
    Selling & General & Admin
    		 125.83M 116.5M 90.31M 71.1M
    Research & Development
    		 466.31M 435.07M 419.98M 229.81M
    Other Expenses
    		 -10.29M -8.98M -7.57M -6.89M
    Operating Expenses
    		 581.86M 542.59M 502.71M 294.01M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 592.14M 551.57M 510.29M 300.9M
    Income Tax Expense
    		 n/a n/a 16.02M -8.17M
    Shares Outstanding (Basic)
    		 98.85M 88.77M 76.97M 70.89M
    Shares Outstanding (Diluted)
    		 98.85M 88.77M 76.97M 70.89M
    EPS (Basic)
    		 -5.25 -5.42 -6.16 -3.78
    EPS (Diluted)
    		 -5.25 -5.42 -6.16 -3.78
    EBITDA
    		 -523.98M -506.31M -450.59M -260.96M
    EBIT
    		 -534.26M -515.29M -458.16M -267.85M
    Depreciation & Amortization
    		 10.29M 8.98M 7.57M 6.89M

    Add to Watchlist